These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23269884)

  • 1. Patient's perception of symptoms related to morning activity in chronic obstructive pulmonary disease: the SYMBOL Study.
    Kim YJ; Lee BK; Jung CY; Jeon YJ; Hyun DS; Kim KC; Yu SK; Choi HS; Shin WH; Lee KH
    Korean J Intern Med; 2012 Dec; 27(4):426-35. PubMed ID: 23269884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between objectively measured physical activity and morning symptoms in COPD.
    van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
    LaForce C; Feldman G; Spangenthal S; Eckert JH; Henley M; Patalano F; D'Andrea P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1233-43. PubMed ID: 27354782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa.
    Kokturk N; Abuharbid W; Albanna AS; Gunen H; Gurgun A; Khadadah M; Malvolti E; Soliman M; van Zyl-Smit R; Zidouni N; Alzaabi A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2959-2970. PubMed ID: 31908444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.
    Stephenson JJ; Cai Q; Mocarski M; Tan H; Doshi JA; Sullivan SD
    Int J Chron Obstruct Pulmon Dis; 2015; 10():577-86. PubMed ID: 25844033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.
    Miravitlles M; Worth H; Soler Cataluña JJ; Price D; De Benedetto F; Roche N; Godtfredsen NS; van der Molen T; Löfdahl CG; Padullés L; Ribera A
    Respir Res; 2014 Oct; 15(1):122. PubMed ID: 25331383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire.
    Núñez A; Esquinas C; Barrecheguren M; Calle M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3837-3844. PubMed ID: 30538445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING).
    Marin JM; Beeh KM; Clemens A; Castellani W; Schaper L; Saralaya D; Gunstone A; Casamor R; Kostikas K; Aalamian-Mattheis M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1425-34. PubMed ID: 27418815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real world COPD: association of morning symptoms with clinical and patient reported outcomes.
    Roche N; Small M; Broomfield S; Higgins V; Pollard R
    COPD; 2013 Dec; 10(6):679-86. PubMed ID: 24127914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR; Schuermann W; Beckman O; Persson T; Polanowski T
    Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey.
    Partridge MR; Karlsson N; Small IR
    Curr Med Res Opin; 2009 Aug; 25(8):2043-8. PubMed ID: 19569976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI).
    Hareendran A; Make BJ; Zaiser E; Garcia Gil E
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1633-1645. PubMed ID: 29849455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyspnea During Night-Time and at Early Morning in Patients with Stable COPD is Associated with Supine Tidal Expiratory Flow Limitation.
    Uccelli S; Pini L; Bottone D; Ranieri P; Orzes N; Tantucci C
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2549-2558. PubMed ID: 33116471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study.
    Kuyucu T; Güçlü SZ; Saylan B; Demir C; Senol T; Güner S; Koyuncu E; Ozen F; Oztürk S; Cangül Z; Ağanoğlu S; Ozkaya S; Ocak SC; Akkurt H; Intepe YS; Bayrak MG; Güler T; Bekçi TT; Soyyiğit S; Seyfettin S; Kula O; Akbay MO; Büyükgöze B; Asal G; Başlilar S; Oztürk O;
    Tuberk Toraks; 2011; 59(4):328-39. PubMed ID: 22233302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The variability of respiratory symptoms and associated factors in COPD.
    Miravitlles M; Izquierdo JL; Esquinas C; Pérez M; Calle M; López-Campos JL; Rodríguez González-Moro JM; Casanova C; Esteban C; de Lucas P
    Respir Med; 2017 Aug; 129():165-172. PubMed ID: 28732827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of night-time symptoms in COPD: a real-world study in five European countries.
    Price D; Small M; Milligan G; Higgins V; Gil EG; Estruch J
    Int J Chron Obstruct Pulmon Dis; 2013; 8():595-603. PubMed ID: 24348032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis.
    Donohue JF; Kerwin E; Barnes CN; Moran EJ; Haumann B; Crater GD
    BMC Pulm Med; 2020 May; 20(1):134. PubMed ID: 32393215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study.
    Scichilone N; Antonelli Incalzi R; Blasi F; Schino P; Cuttitta G; Zullo A; Ori A; Canonica GW;
    BMC Pulm Med; 2019 Sep; 19(1):171. PubMed ID: 31500607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.
    Tabberer M; Brooks J; Wilcox T
    Health Qual Life Outcomes; 2015 Oct; 13():177. PubMed ID: 26520062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.